Following are the day’s biggest winners and losers. Find out why shares of First Solar and American Express popped while Target and MetLife dropped.
Here's the question: your company has cut discretionary costs and has laid off a group of workers, but still needs to cut more. Your choice is between cutting pay and requiring a furlough. What's an executive to do?
Instead of asking what Warren Buffett has been buying, we should have been wondering what he's been selling. Berkshire Hathaway's stock portfolio snapshot for the end of the fourth quarter reveals its holdings in Johnson and Johnson have been slashed by more than half.
Since the Super Bowl turned into the ad game, advertisers have become obsessed with scoring big on USA Today's Ad Meter. It is, after all, considered the gold standard of all advertising metrics.
Every year, the folks at America's Milk Processors do an ad with the Super Bowl stars and put it in USA Today . It's normally a good bit, with the players sporting those now familiar milk mustaches. But this year's ad clearly doesn't work.
At least six CEOs of publicly traded companies have been fired since the start of the New Year and we're only halfway through January. Experts say CEO firings double during bad times. And talk about bad times.
Cramer makes the call on viewers' favorite stocks.
Warren Buffett's Berkshire Hathaway sharply increased its stake in ConocoPhillips this spring and summer, accumulating a total of 84 million shares as of the end of the third quarter on September 30, according to Berkshire's just-released quarterly portfolio filing with the SEC.
Blogging about staff cuts is particularly prevalent in Silicon Valley, where companies feel pressure to break bad news on their own blogs so that they can better control the message.
The final week of October promises to be volatile and even scary, but traders are holding out hope that it's the month where stocks finally hit bottom, even if it means another stinging downdraft before it's over.
Friday couldn't come fast enough for stock investors. Thursday, like most of the week, was punctuated by wild, gut wrenching swings. Friday doesn't look like it will be much different.
The stock market is on its own wild ride these days, but if investors were to step off the roller coaster for a minute, they might see signs of life in the credit markets.
Stocks will take their cue from credit markets in the week ahead and whether they are responding to any of the government's efforts to thaw the glacial credit freeze.
It's a tough time for newspaper and magazine publishers. This week, "The Sun," the six-year old daily newspaper, printed its final paper. The conservative-oriented paper searched for new financial backers for nearly a month, and finding no private equity interest, had to shut down. Meanwhile Variety, the 103-year old Hollywood trade publication, can't find a buyer.
Earlier this week, we wrote about the highest yielding stocks on the Dow. The S&P 500 also has some nice yielding stocks. If you are worried about the financials being able to continue to pay thier big dividends (with Freddie Mac's big slide, its yield is now over 20%!), there are nearly 40 stocks on the S&P that are currently yielding 5% or more. Here's a breakdown.
Medal Round - Day 5: Half way through the medal round, the playing field continues to shift. The US' S&P 500 looks poised to stay on track for the gold, but the silver and bronze are up for grabs.
Warren Buffett's Berkshire Hathaway has added a new stake in NRG Energy, according to a just-released portfolio 'snapshot' of its holdings in U.S. publicly-traded stocks as of June 30. A sharply reduced stake in Anheuser-Busch may have been a bet that InBev's initially unsolicited offer for the U.S. brewer would prove to be unsuccessful. Conoco-Phillips data is kept "confidential."
Stocks closed higher, with bank shares rising broadly, though the market pulled back from its biggest gains as oil stemmed its slide.
Gannett plans to eliminate 1,000 positions from its local newspapers around the U.S. because of declining advertising and circulation revenue, and may cut more if those conditions persist.
John Dorfman's prescription for a portfolio: A pharmaceutical, a defense contractor, a media company, and a technology stock.